DA Davidson Lowers UiPath (NYSE:PATH) Price Target to $13.00

by · The Cerbat Gem

UiPath (NYSE:PATH – Get Free Report) had its price target dropped by stock analysts at DA Davidson from $15.00 to $13.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. DA Davidson’s price target suggests a potential upside of 15.43% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. Royal Bank Of Canada set a $14.00 price target on shares of UiPath in a research report on Wednesday, February 11th. Wells Fargo & Company cut their price objective on shares of UiPath from $14.00 to $13.00 and set an “equal weight” rating on the stock in a research note on Thursday. Needham & Company LLC raised shares of UiPath from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a report on Thursday. Canaccord Genuity Group boosted their target price on shares of UiPath from $15.00 to $19.00 and gave the company a “buy” rating in a research report on Thursday, December 4th. Finally, Wall Street Zen lowered shares of UiPath from a “strong-buy” rating to a “buy” rating in a report on Sunday, February 8th. Two analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, UiPath currently has a consensus rating of “Hold” and a consensus price target of $14.86.

View Our Latest Stock Analysis on UiPath

UiPath Price Performance

UiPath stock traded down $1.12 during trading hours on Thursday, hitting $11.26. 31,561,519 shares of the stock traded hands, compared to its average volume of 33,505,078. The firm’s 50 day moving average price is $13.15 and its 200-day moving average price is $13.99. The stock has a market capitalization of $6.02 billion, a price-to-earnings ratio of 27.38, a P/E/G ratio of 1.58 and a beta of 1.09. UiPath has a 1 year low of $9.38 and a 1 year high of $19.84.

UiPath (NYSE:PATH – Get Free Report) last released its earnings results on Wednesday, March 11th. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.05. The firm had revenue of $481.11 million during the quarter, compared to the consensus estimate of $464.81 million. UiPath had a return on equity of 3.73% and a net margin of 14.79%.The company’s revenue was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.26 earnings per share. Research analysts forecast that UiPath will post -0.17 earnings per share for the current fiscal year.

Insider Activity at UiPath

In other news, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $15.73, for a total transaction of $707,850.00. Following the completion of the transaction, the chief executive officer directly owned 28,343,585 shares of the company’s stock, valued at $445,844,592.05. The trade was a 0.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Ashim Gupta sold 67,468 shares of the business’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the completion of the transaction, the chief financial officer owned 557,028 shares of the company’s stock, valued at approximately $8,968,150.80. This represents a 10.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 832,468 shares of company stock valued at $13,668,235. Insiders own 23.19% of the company’s stock.

Institutional Investors Weigh In On UiPath

A number of institutional investors have recently modified their holdings of the business. Corient Private Wealth LLC increased its stake in shares of UiPath by 5.6% in the 4th quarter. Corient Private Wealth LLC now owns 27,283 shares of the company’s stock valued at $447,000 after purchasing an additional 1,455 shares in the last quarter. Avory & Company LLC purchased a new position in UiPath during the fourth quarter worth approximately $275,000. Invesco Ltd. grew its holdings in UiPath by 32.1% in the fourth quarter. Invesco Ltd. now owns 1,202,277 shares of the company’s stock valued at $19,705,000 after purchasing an additional 292,134 shares during the period. Mercer Global Advisors Inc. ADV grew its holdings in UiPath by 31.4% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 38,330 shares of the company’s stock valued at $619,000 after purchasing an additional 9,151 shares during the period. Finally, Skyview Financial Group LLC purchased a new stake in shares of UiPath in the fourth quarter valued at approximately $2,794,000. 62.50% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting UiPath

Here are the key news stories impacting UiPath this week:

  • Positive Sentiment: Q4 beat — UiPath reported revenue of $481.1M and non‑GAAP EPS $0.30, both topping Street expectations; ARR grew to $1.853B, supporting the company’s narrative of enterprise AI adoption moving to scaled deployment. Read More.
  • Positive Sentiment: Capital return and long‑term targets — management set a $2B ARR target for FY27 and unveiled a $500M buyback, which reduces float and can support EPS and investor sentiment over time. Read More.
  • Neutral Sentiment: Near‑term revenue guide mostly in line — UiPath gave Q1 revenue guidance slightly above Street at the midpoint (~$397.5M), which is a modest beat but not strong enough to offset concerns about FY growth deceleration. Read More.
  • Neutral Sentiment: Unusual options activity — elevated call buying (≈94,510 contracts) signals active trader interest but could reflect short‑term speculation rather than conviction.
  • Negative Sentiment: Guidance and growth deceleration spooked investors — despite the beat, management’s outlook implies slower full‑year revenue growth, prompting a post‑earnings selloff and after‑hours slide. Read More.
  • Negative Sentiment: Analyst pushback — Morgan Stanley cut its price target from $19 to $17 and moved to an “equal weight” stance, a sign some sell‑side desks are trimming expectations despite upside potential cited. Read More.
  • Negative Sentiment: Market skepticism remains — commentary highlights decelerating revenue growth and questions about how much AI adoption will translate into sustained upside, keeping the bull case tempered. Read More.

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Featured Articles